The National Cancer Institute has renewed its license for Ariadne's Pathway Studio Enterprise system, which includes the ResNet Mammalian database and Ariadne MedScan text processing technology.
Ilya Mazo, Ariadne’s president, said in a statement that the firm “welcome[s]” the opportunity to provide its “bioinformatics expertise” to help NCI researchers with data capture and curation and to support collaborations between research institutes.
Pathway Studio lets researchers create new cancer disease pathways and develop rationales for diseases based on molecular facts from public data and research findings using MedScan.
The tool uses a workflow approach that allows researchers to mine, integrate, analyze, and visualize results individually or as an integrated workflow. Each step can be saved and updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.
Last month, Pathway studio was tapped to support cancer research endeavors at Georgetown University (BI 02/11/2011).